1. Home
  2. MCI vs OVID Comparison

MCI vs OVID Comparison

Compare MCI & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barings Corporate Investors

MCI

Barings Corporate Investors

HOLD

Current Price

$17.55

Market Cap

362.0M

Sector

Finance

ML Signal

HOLD

Logo Ovid Therapeutics Inc.

OVID

Ovid Therapeutics Inc.

HOLD

Current Price

$2.80

Market Cap

365.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCI
OVID
Founded
1971
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
362.0M
365.5M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
MCI
OVID
Price
$17.55
$2.80
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$4.60
AVG Volume (30 Days)
45.5K
3.0M
Earning Date
01-01-0001
05-13-2026
Dividend Yield
8.46%
N/A
EPS Growth
N/A
3.90
EPS
1.82
N/A
Revenue
N/A
$7,252,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$19.34
P/E Ratio
$9.64
N/A
Revenue Growth
N/A
1181.27
52 Week Low
$17.24
$0.27
52 Week High
$23.00
$3.11

Technical Indicators

Market Signals
Indicator
MCI
OVID
Relative Strength Index (RSI) 40.88 60.07
Support Level $17.27 $2.56
Resistance Level $18.19 $3.11
Average True Range (ATR) 0.34 0.15
MACD 0.07 -0.03
Stochastic Oscillator 41.30 55.68

Price Performance

Historical Comparison
MCI
OVID

About MCI Barings Corporate Investors

Barings Corporate Investors is a closed-end management investment company. Its investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. The Trust's principal investments are privately placed, below-investment grade, long-term debt obligations, including bank loans and mezzanine debt instruments. The Trust typically purchases these investments, which are not publicly tradable, directly from their issuers in private placement transactions, and the investments are typically made to small or middle market companies.

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

Share on Social Networks: